Author: Aruna Dontabhaktuni
-
Enhance Your Pharmacometric Analysis with R: Hands-On Self-Paced
Join the “Learn R for Pharmacometrics” workshop led by Aruna Dontabhaktuni, Ph.D,—Founder and Scientific Director of Project Dontabhaktuni, Founder & CEO of PharmaPro Consulting, and Adjunct Professor at the University of the Pacific. Workshop Highlights: Early Bird Access: Register now—the first few participants will have free access to the workshop. Thank you to our sponsor,…
-
Exciting News! President Biden Expands White House Initiative on
Exciting News! President Joe Biden signed a groundbreaking Executive Order on March 18, 2024, expanding the White House Initiative on Women’s Health Research. This initiative marks a significant step towards addressing women’s health issues through enhanced funding, research, and collaboration. Notably, a $12 billion investment proposal for the NIH has been introduced to establish a…
-
Our CEO Dr. Dontabhaktuni’s Achievement Featured on Women’s Story
Delighted to highlight the extraordinary journey of Dr. Aruna Dontabhaktuni, whose impactful contributions to the pharmaceutical sector continue to inspire. As the Founder and CEO of PharmaPRO Consulting, Dr. Dontabhaktuni has demonstrated unparalleled expertise in clinical pharmacology and regulatory affairs over 25 years. We’re proud to announce that Dr. Aruna Dontabhaktuni’s exceptional achievements have been…
-
Aruna Dontabhaktuni Wins International Women Entrepreneur Award
We are thrilled to share the exciting news that Dr. Aruna Dontabhaktuni, Founder and CEO of PharmaPRO Consulting Inc., has been honored with the prestigious International Women Entrepreneur Award 2024 by Great Companies. Dr. Dontabhaktuni’s innovative leadership and unwavering dedication have propelled PharmaPRO Consulting to the forefront of the pharmaceutical consulting industry. Despite facing challenges…
-
Aruna Dontabhaktuni Wins Pitch Competition at WBEC Awards
WBEC’s broad and expanding membership affords a direct view of the significant contributions made by women propelling economic development in the New York region, exemplified by figures like Aruna Dontabhaktuni, Ph.D., Founder & CEO of PharmaPro Consulting. Pharma Pro’s integration of mathematical modeling has been pivotal in optimizing drug development processes, leading to reduced timelines…
-
Our CEO Dr. Dontabhaktuni Recognized by HER FORWARD Magazine
This workshop will equip participants with the skills and knowledge necessary to excel in non-compartmental analysis (NCA). NCA is a method to describe pharmacokinetic data used to assess how a drug behaves in the body. It provides key insights into a drug’s absorption, distribution, metabolism, and elimination. By examining parameters like maximum concentration (Cmax), area…
-
Antibody-Drug Conjugates
The future of Antibody-Drug Conjugates (ADCs) in drug development is promising and dynamic, with numerous exciting prospects on the horizon. Over 100 ADCs are currently under preclinical and early-stage clinical research, highlighting the significant investment in advancing this therapeutic class. Researchers are shifting their focus from targeting oncogenic driver mutations to exploring antigens that are…
-
PharmaPRO Selected in Ten finalists at WBENC NY Pitch Competition
We are excited to share that PharmaPRO has been selected as the Ten finalists in the WBENC Pitch Competition on Aug 30 2023.It’s with immense pride we share about PharmaPro and our mission—PharmaPro is a unique company that employs only the top pharmaceutical scientists. We are committed to using state-of-the-art science and thinking outside the…
-
Project Dontabhaktuni is Creating a “Virtual Toastmasters Club”
Learning Objectives: Toastmasters is a non-profit organization that helps people improve their communication and leadership skills through a supportive and structured program. An online Toastmasters club is a virtual platform where members meet to practice public speaking, impromptu speaking, and leadership skills. The online format provides a convenient and flexible way for members to participate…
-
Use of AI and ML in Drug Development and Regulatory Submissions
Artificial Intelligence (AI) and Machine Learning (ML) are rapidly changing the landscape of drug development and regulatory submissions. In recent years, these technologies have gained significant attention and have been increasingly adopted by pharmaceutical companies and regulatory agencies alike. Regulatory submissions are a critical aspect of drug development, and they involve submitting a vast amount…